000 | 01690 a2200457 4500 | ||
---|---|---|---|
005 | 20250517202145.0 | ||
264 | 0 | _c20180918 | |
008 | 201809s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2018.01.055 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDjagbare, Matieyendou Didier | |
245 | 0 | 0 |
_aMonoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine. _h[electronic resource] |
260 |
_bVaccine _c03 2018 |
||
300 |
_a1673-1680 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 |
_aEpitopes _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunogenicity, Vaccine |
650 | 0 | 4 |
_aImmunoglobulin G _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNeutralization Tests |
650 | 0 | 4 |
_aRespiratory Syncytial Virus Infections _xprevention & control |
650 | 0 | 4 |
_aRespiratory Syncytial Virus, Human _ximmunology |
650 | 0 | 4 | _aStress, Physiological |
650 | 0 | 4 |
_aVaccines _ximmunology |
650 | 0 | 4 |
_aViral Fusion Proteins _ximmunology |
700 | 1 | _aYu, Li | |
700 | 1 | _aParupudi, Arun | |
700 | 1 | _aSun, Jenny | |
700 | 1 | _aCoughlin, Melissa L | |
700 | 1 | _aRush, Benjamin S | |
700 | 1 | _aSanyal, Gautam | |
773 | 0 |
_tVaccine _gvol. 36 _gno. 12 _gp. 1673-1680 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2018.01.055 _zAvailable from publisher's website |
999 |
_c28098191 _d28098191 |